A delegation from Jazeera Pharmaceutical Industries (JPI) recently visited King Saud University’s Petrochemicals Research Chair (PRC), which under the leadership of Professor Salem Al-Deyab has established strong ties with industrial companies in the private sector. The delegation for JPI, one of Saudi Arabia's major pharmaceutical manufacturers, included Amer Abdul-Rahim, Director of Research and Developmnt, and Abdullah Al-Baqmi Director of General Safety, Environment Security and Social Responsibility.
Discussions between Dr. Al-Deyab and JPI regarding the development and improvement of medical drugs, has resulted in the establishment of a KSU-JPI cooperation project. The partnership's first program has been an agreement to enroll one Masters student to help develop JPI products after carrying out research and its practical applications under the joint supervision of PRC and JPI's Directorate of Research.
Dr. Al-Deyab, who also serves as the University's MS program for Polymers coordinator, said the meeting reflects the determination of both the PRC and MS Program to link scientific research with practical research that can serve the community.
He said the visit also reflects one of the PRC's most important objectives, which is to reach out to industry and learn what their interests happen to be, and to draft matching research plans that will contribute to various domains such as medical, industrial, water desalination, environment and energy.
It should be noted that vigorous cooperation is talking place between the PRC and the Saudi Basic Industries Corporation (SABIC), which has resulted in one MS student's development of industrial catalysts essential to petro-industries. In addition, the Chair's cooperation with King Faisal Specialist Hospital has produced research which has resulted the design of new wound bandages.
The Petrochemicals Research Chair is affiliated to KSU’s College of Sciences, which was founded in 1958. The PRC was established in the summer of 2008 and conducts research and development in the area of petrochemicals, through the its faculty's distinguished scientific skills and advanced laboratory technology. It also provides invaluable training courses and technical services, as well as consultation, to specialized companies.
Jazeera Pharmaceutical Industries (JPI) is the first Gulf company to receive FDA approval for its drug manufacturing facilities. Established in 1999, its main objective is to manufacture and market high quality healthcare products at a reasonable cost, satisfying patient needs in Saudi Arabia and other neighboring markets. JPI endeavors to assist the Kingdom in establishing regional self-sufficiency in health care products and to play an important role in enhancing the nation's economic development.